BlueChew MAX review: ingredients and format
Research checked October 1, 2026
BlueChew MAX belongs in the compounded sublingual combination part of the Form & Function field guide. Its named ingredient profile is sildenafil and tadalafil. Format is a genuine difference to understand, alongside active ingredients and the prescription schedule.
The current MAX page describes a sublingual combination of sildenafil 45 mg and tadalafil 18 mg. This identifies MAX as a specific two-ingredient product, distinct from BlueChew's single-active lines and its vardenafil-containing VMAX. This makes the label and administration instructions more informative than the brand name alone; the reader should know what the individual pharmacy order actually contains.
Product at a glance
- Format
- Compounded sublingual combination
- Ingredients or route
- Sildenafil and tadalafil
- Verified source
- Current official product page ↗
Composition and dosage form
BlueChew markets MAX around onset and a longer responsiveness window. Those statements are provider claims; they do not establish that the product is clinically better for every person or that two PDE5 inhibitors should be taken together without a prescription.
The route described on the page involves dissolving the medication under the tongue. Administration, food effects, instructions for previous ED medicines and the exact dispensed formulation belong in the clinician conversation before judging the format on convenience.
Where the format fits
A compounded combination is its own finished formulation. Individual approved ingredients do not make the combined chew, sublingual tablet or suspension FDA-approved, nor do they prove a particular absorption pattern or onset for every person.
Product-specific comparison
The current MAX page lists sildenafil 45 mg and tadalafil 18 mg. VMAX lists a different short-acting ingredient, and GOLD adds two additional ingredients. A reader should write down MAX's actual pair before comparing the product with another combination. Ro Sparks, for example, lists the same two ingredient names with different active amounts and a separately branded sublingual formulation. Those observations support a composition comparison, not a calculation of which product is clinically stronger. Ask the prescriber why this particular formula is selected and what follow-up would justify changing it.
A useful comparison
MAX belongs in a combination-format comparison rather than a table that ranks all sildenafil products as interchangeable. Readers who have tried one medicine should ask whether the previous attempt was optimized before assuming a dual-active formula is the next step.
Record three separate fields: the active ingredients, the physical dosage form and the prescribed schedule. None can substitute for the other. A convenient format can still be a complex formula, and an approved ingredient can still appear in an unapproved compounded product. The pharmacy label should resolve the final product identity.
Prescription boundaries
The compounded product is not FDA-approved. Do not copy the listed strengths to create your own combination from tablets acquired elsewhere.
Ask the provider or check the current label: What is the reason for combining sildenafil and tadalafil in my prescription, and how will adverse effects be monitored? Keep the answer with the order details so the next comparison is based on the product you will actually use.
Sources and verification
Official product pages support product identity and advertised terms. Clinical sources provide general context. Provider claims are identified as claims; this article does not report a patient trial.
- bluechew.com/max
- niddk.nih.gov/health-information/urologic-diseases/erectile-dysfunction/treatment
- fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
Fresh public-page research captured October 1, 2026 using TinyFish. Full capture records and page hashes are retained in the project research directory.